Report ID: 10077049 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Point of Care Blood Gas and Electrolyte Market Highlights Over 2022 - 2031
The global point of care blood gas and electrolyte market is estimated to grow at a ~5% CAGR over the forecast period, i.e., 2022 – 2031. Moreover, the market registered a revenue of approximately USD 766.0 million in 2021. The growth of the market can be attributed to the surge in non-communicable diseases. According to the Centers for Disease Control and Prevention, approximately 41 million people die every year owing to non-communicable diseases. Moreover, the growing awareness among people related to the convenient use of portable point of care devices is further expected to increase the growth of the global point-of-care blood gas and electrolyte market.
GET A SAMPLE COPY OF THIS REPORT
The global point of care blood gas and electrolyte market is segmented by end-user into the diagnostic center, hospitals & clinics, pharmacy, home care, and research institutes. Out of these, the home care segment is anticipated to hold the largest share over the forecast period in the market owing to the growing awareness among the people related to the availability of point of care products and the rise in the percentage of the population dealing with chronic diseases. Therefore, such a factor is anticipated to increase the growth of the home care segment.
Global Point of Care Blood Gas and Electrolyte Market Regional Synopsis
Regionally, the global point of care blood gas and electrolyte market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region is estimated to witness modest growth over the forecast period on the back of a rise in chronic diseases and growing awareness among the population related to point-of-care devices for the detection of disease at an earlier stage. According to the National Library of Medicine, approximately 50 percent of the population in the U.S suffers from at least one chronic disease. Moreover, there has been a surge in the demand for point-of-care devices from people which is expected to drive the growth of the market in the region.
Market Segmentation
Our in-depth analysis of the global point of care blood gas and electrolyte market includes the following segments:
By End-User
-
Diagnostic Center
-
Hospital & Clinics
-
Pharmacy
-
Home Care
-
Research Institutes
By Product Type
-
Electrolyte Analyzer
-
Blood Gas Analyzer
-
Consumables
-
Combined Analyzer
Growth Drivers and Challenges Impacting the Growth of the Global Point of Care Blood Gas and Electrolyte Market
Growth Drivers
-
Surge in Non-Communicable Diseases
-
Growing Awareness Among the People Related to the Convenience Use of Portable Point of Care Devices
Challenges
-
High Cost of the Point of Care Blood Gas and Electrolyte Devices
-
Chances of Error in the test Results from the Point of Care Blood Gas and Electrolyte Devices
Key Companies Dominating the Global Point of Care Blood Gas and Electrolyte Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global point of care blood gas and electrolyte market that are included in our report are Siemens Healthcare GmbH, Abbott, Nova Medical, Sensa Care, EDAN Instruments, Inc., Medica Corporation, F. Hoffmann-La Roche Ltd, Anteo Tech, Becton, Dickinson and Company, and others.
Latest Developments in the Global Point of Care Blood Gas and Electrolyte Market:
-
12 January 2022: F. Hoffmann-La Roche Ltd, launched first professional blood glucose management solution cobas pulse system with mobile digital health capabilities to improve patient care.
-
9 March 2022: Nova Biomedical launched Nova Max Pro Creatinine/eGFR Meter System in all CE countries. Nova Max Pro is an important new tool for improving kidney care in outpatient settings by screening for kidney function and detecting kidney disease early.
Key Reasons to Buy Our Report
-
The report covers a detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Frequently Asked Question
The market is segmented by end-user, product type, and by region.
The home care segment is anticipated to hold largest market size in value over the forecast period and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10077049 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
